Calcitriol 1μg

Calcitriol 1μg
Product Description

1. Efficacy & Effectiveness

1) Treatment for hypocalcemia in chronic kidney dialysis patients.

2) Improvement of skeletal dysplasia by remarkable reducing elevated parathyroid hormone levels.

2. Administration & Dosage

The initial recommended dose of the drug, as calcitriol, is administered three times a week with 0.5 µg (about 0.01 µg per kg body weight) every other day. the drug, an IV bolus, can be administered through a catheter at the end of hemodialysis. If a satisfactory response does not appear on the biochemical reference ​​and clinical observation, the amount is increased from 0.25 to 0.50 ㎍ every 2 to 4 weeks. Most patients on hemodialysis show an effect at a dose of 0.5 to 3.0 µg (0.05 to 0.05 µg per kg body weight) three times a week. ○ Cautions for use 1) Serum calcium and phosphorus levels should be measured at least twice a week during the appropriate period...

YUYU PHARMA

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2023
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
Distributor/Import Export
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Finished Formulation products Distributor/Buyer
OTC
Pharmaceutical Company (generic finished products)
Specifications

YUYU PHARMA

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2023
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
Distributor/Import Export
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Finished Formulation products Distributor/Buyer
OTC
Pharmaceutical Company (generic finished products)

More Products from YUYU PHARMA (2)

  • Bonky soft capsule (Calcitriol 0.25μg)

    Product Bonky soft capsule (Calcitriol 0.25μg)

    1. In patients with chronic renal failure:• Pre-dialysis stage patients 
    .• Patients on hemodialysis with renal osteodystrophy
    2. Hypoparathyroidism(post-surgical, idiopathic, or pseudo-hypoparathyroidism)
    3. Rickets and osteomalacia(Vitamin D-dependent rickets, vitamin D-resistant rickets&nb...
  • Dutasteride and Tadalafil Tablet 0.5/5 mg

    Product Dutasteride and Tadalafil Tablet 0.5/5 mg

    We have developed novel combination of marketed individual Dutasteride and Tadalafil (Avodart + Cialis) for BPH indication. The combination of tadalafil with dutasteride provide better therapeutic effect in improvement of BPH and LUTs symptoms while reduce adverse effect profile particularly Erectile d...